Trials / Completed
CompletedNCT03331263
Single Dose CHG Pharmacokinetic Study
Single Dose Pharmacokinetic Study to Assess the Systemic Exposure of Chlorhexidine From ReadyPrep® CHG (2% Chlorhexidine Gluconate Cloth)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Medline Industries · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the same procedure as Treatment-1 and -2 was performed, but without the topical application of ReadyPrep® CHG. The treatments were separated by a wash-out of 7 calendar days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chlorhexidine Gluconate | 2% CHG |
Timeline
- Start date
- 2017-07-21
- Primary completion
- 2017-08-06
- Completion
- 2017-08-06
- First posted
- 2017-11-06
- Last updated
- 2023-12-15
- Results posted
- 2023-12-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03331263. Inclusion in this directory is not an endorsement.